BACKGROUND: Although colonoscopy plays an important role in postoperative surveillance of patients with colorectal cancer, the optimum protocol for colonoscopic surveillance has not been established. OBJECTIVE: Our purpose was to compare the efficacy of 2 different colonoscopic surveillance strategies in terms of both survival and recurrence resectability. DESIGN: Prospective, randomized, controlled trial. SETTING: A teaching hospital in Sun Yat-sen University. PATIENTS: Three hundred twenty-six consecutive patients undergoing radical surgery for colorectal cancer. INTERVENTION: In the intensive colonoscopic surveillance group (ICS group, n = 165), colonoscopy was performed at 3-month intervals for 1 year, at 6-month intervals for the next 2 years, and once a year thereafter. In the routine colonoscopic surveillance group (RCS group, n = 161), colonoscopy was performed at 6 months, 30 months, and 60 months postoperatively. MAIN OUTCOME MEASUREMENTS AND RESULTS: The 5-year survival rate was 77% in the ICS group and 73% in the RCS group (P > .05). Postoperative colorectal cancer was detected in 13 patients (8.1%) in the ICS group and in 18 patients (11.4%) in the RCS group. In the ICS group, there were more asymptomatic postoperative colorectal cancers (P = .04), more patients had reoperation with curative intent (P = .048), and the probability of survival after postoperative colorectal cancer was higher (P = .03). LIMITATION: Lack of detailed characterization of metachronous colorectal adenomas in these patients. CONCLUSIONS: Although the patients in the ICS group had more curative operations for postoperative colorectal cancer and survived significantly longer, ICS itself did not improve overall survival.
RCT Entities:
BACKGROUND: Although colonoscopy plays an important role in postoperative surveillance of patients with colorectal cancer, the optimum protocol for colonoscopic surveillance has not been established. OBJECTIVE: Our purpose was to compare the efficacy of 2 different colonoscopic surveillance strategies in terms of both survival and recurrence resectability. DESIGN: Prospective, randomized, controlled trial. SETTING: A teaching hospital in Sun Yat-sen University. PATIENTS: Three hundred twenty-six consecutive patients undergoing radical surgery for colorectal cancer. INTERVENTION: In the intensive colonoscopic surveillance group (ICS group, n = 165), colonoscopy was performed at 3-month intervals for 1 year, at 6-month intervals for the next 2 years, and once a year thereafter. In the routine colonoscopic surveillance group (RCS group, n = 161), colonoscopy was performed at 6 months, 30 months, and 60 months postoperatively. MAIN OUTCOME MEASUREMENTS AND RESULTS: The 5-year survival rate was 77% in the ICS group and 73% in the RCS group (P > .05). Postoperative colorectal cancer was detected in 13 patients (8.1%) in the ICS group and in 18 patients (11.4%) in the RCS group. In the ICS group, there were more asymptomatic postoperative colorectal cancers (P = .04), more patients had reoperation with curative intent (P = .048), and the probability of survival after postoperative colorectal cancer was higher (P = .03). LIMITATION: Lack of detailed characterization of metachronous colorectal adenomas in these patients. CONCLUSIONS: Although the patients in the ICS group had more curative operations for postoperative colorectal cancer and survived significantly longer, ICS itself did not improve overall survival.
Authors: Elena Elimova; Xuemei Wang; Wei Qiao; Kazuki Sudo; Roopma Wadhwa; Hironori Shiozaki; Yusuke Shimodaira; Venkatram Planjery; Nikolaos Charalampakis; Jeffrey H Lee; Brian R Weston; Manoop S Bhutani; Ritsuko Komaki; David C Rice; Stephen G Swisher; Mariela A Blum; Jane E Rogers; Heath D Skinner; Dipen M Maru; Wayne L Hofstetter; Jaffer A Ajani Journal: Oncology Date: 2018-04-27 Impact factor: 2.935
Authors: Charles J Kahi; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas J Robertson; Douglas K Rex Journal: Am J Gastroenterol Date: 2016-02-12 Impact factor: 10.864
Authors: Minna Räsänen; Monika Carpelan-Holmström; Harri Mustonen; Laura Renkonen-Sinisalo; Anna Lepistö Journal: Int J Colorectal Dis Date: 2015-03-22 Impact factor: 2.571
Authors: Eric P van der Stok; Manon C W Spaander; Dirk J Grünhagen; Cornelis Verhoef; Ernst J Kuipers Journal: Nat Rev Clin Oncol Date: 2016-12-20 Impact factor: 66.675
Authors: Victoria Giglio; Patricia Schneider; Kim Madden; Bill Lin; Iqbal Multani; Hassan Baldawi; Patrick Thornley; Leen Naji; Marc Levin; Peiyao Wang; Anthony Bozzo; David Wilson; Michelle Ghert Journal: Oncol Rev Date: 2021-06-24
Authors: Perry J Pickhardt; Kristin Edwards; David H Bruining; Marc Gollub; Sonja Kupfer; Sam J Lubner; David H Kim; Eric Ross; Eileen Keenan; David S Weinberg Journal: Dis Colon Rectum Date: 2017-11 Impact factor: 4.585